Consolidated Balance Sheets - USD ($)	Apr. 30, 2023	Jul. 31, 2022
Current Assets
Cash	$ 58,048	$ 718
Loan receivable	358,685	336,480
Accrued interest income	4,163	0
Total Current Assets	420,896	337,198
Construction in progress	479,810	0
Investment	2,679,500	0
TOTAL ASSETS	3,580,206	337,198
Current Liabilities
Accounts payable and accrued liabilities	192,690	13,075
Deferred interest income	0	6,748
Due to related parties	3,210,022	8,812
Total Current Liabilities	3,402,712	28,635
TOTAL LIABILITIES	3,402,712	28,635
Equity
Common stock: 300,000,000 authorized; $0.001 par value 586,686 and 595,986 shares issued and outstanding, respectively	587	596
Additional paid in capital	331,114	331,105
Accumulated deficit	(154,306)	(23,238)
Total stockholders' equity.	177,495	308,563
Noncontrolling interests	(1)	0
Total Equity	177,494	308,563
TOTAL LIABILITIES AND EQUITY	3,580,206	337,198
Series A Preferred Stock
Equity
Preferred stock: 10,000,000 authorized; $0.001 par value Series A preferred stock 100,000 designated; $0.001 par value 100,000 shares issued and outstanding	$ 100	$ 100

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.